BSE filing, NSE: FRASER. Summary written from the filing by ALFA Finder's alert engine.
Fraser & Company Ltd: key numbers
- Share price
- ₹7.51
- Market cap
- ₹6.10 Cr
- Revenue (annual)
- ₹1.36 Cr
- Net profit (annual)
- ₹-0.61 Cr
- P/E (TTM)
- -7.5×Sector 45.0×
- Promoter holding
- 3.12%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fraser & Company Ltd
All →Fraser & Company Other Announcement
Fraser and Company Limited has submitted a disclosure confirming that the Regulation 32 statement of deviation or variation is not applicable for the quarter ended September 2026.
Fraser & Company Management Change
Fraser and Company redesignated Ms. Rekha Rani Naraniwal from Additional Non-Executive Independent Director to Non-Executive Independent Director effective 17-Sept-2026. No transaction or monetary value is involved.
Fraser & Company Annual General Meeting
Fraser and Company Limited held its 108th Annual General Meeting on September 17, 2026. The meeting covered financial adoption, director appointments, and object clause alteration.
Fraser & Company Annual General Meeting
Fraser and Company Limited has scheduled its Annual General Meeting for September 17, 2026. The company also announced a book closure from September 11 to September 17, 2026.
Fraser & Company Annual Report
Fraser and Company Limited has submitted its Annual Report for the financial year 2025-2026, which includes the notice for its 108th Annual General Meeting.
Fraser & Company Annual General Meeting
Fraser and Company Limited will hold its Annual General Meeting on September 17, 2026, to discuss financial statements, director appointments, and object clause amendments.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.